Vorapaxar-d5 Sulfate

Vorapaxar-d5 Sulfate Chemische Eigenschaften,Einsatz,Produktion Methoden

• Verwenden

  Labelled Vorapaxar (V758200). SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients.

Vorapaxar-d5 Sulfate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(3)Suppliers